The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Short Talk: The Next Generation Diarylquinoline TBAJ 587 has Superior Efficacy Against, and Restricts Selection of, Bedaquiline Resistant Rv0678 Mutants in a Mouse Model of Tuberculosis